Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy

Epilepsia. 1998 Jul;39(7):799-803. doi: 10.1111/j.1528-1157.1998.tb01167.x.
No abstract available

MeSH terms

  • Anticonvulsants / therapeutic use*
  • Chronic Disease
  • Clinical Trials as Topic / methods*
  • Drug Approval
  • Epilepsy / drug therapy*
  • Guidelines as Topic
  • Humans
  • Product Surveillance, Postmarketing
  • Research Design / standards
  • United States
  • United States Food and Drug Administration


  • Anticonvulsants